UroGen Pharma URGN
NASDAQ URGN
$41.40 +0.85 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Cost of Revenue (2017 - 2026)

Updated

UroGen Pharma (URGN) reported Cost of Revenue of $6.57 million for Q2 2026, up 85.1% from $3.55 million a year earlier and up 58.8% from the prior quarter.

Analysis

UroGen Pharma (URGN) Cost of Revenue (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, UroGen Pharma's Cost of Revenue came in at $17.28 million, up 59.9% year-over-year; for FY2025, it came in at $12.45 million, up 40.2% from FY2024.

  • Cost of Revenue has a five-year compound annual growth rate of 65.3% (FY2020 to FY2025).
  • By year, Cost of Revenue came in at $8.88 million in FY2024 (-5.1%), $9.36 million in FY2023 (+22.3%), $7.65 million in FY2022 (+48.4%) and $5.16 million in FY2021 (+411.1%).
  • The Q2 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2017.
  • Year over year, Cost of Revenue has now increased in each of the last eight quarters, with growth averaging 41.9% over the last eight quarters.
  • The high point for year-over-year Cost of Revenue in five years was Q3 2021 (growth of 302.6%); the low point was Q1 2024 (a decline of 23.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.14 million (Q1 2026), $3.29 million (Q4 2025) and $3.28 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 UroGen Pharma 2.02 Bn 1.53 Bn 65.88 Mn 6.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.57 Mn
Mar 31, 2026 4.14 Mn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 3.28 Mn
Jun 30, 2025 3.55 Mn
Mar 31, 2025 2.33 Mn
Dec 31, 2024 2.47 Mn
Sep 30, 2024 2.45 Mn
Jun 30, 2024 2.23 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 2.29 Mn
Sep 30, 2023 2.37 Mn
Jun 30, 2023 2.44 Mn
Mar 31, 2023 2.27 Mn
Dec 31, 2022 2.26 Mn
Sep 30, 2022 2.02 Mn
Jun 30, 2022 1.85 Mn
Mar 31, 2022 1.53 Mn
Dec 31, 2021 1.59 Mn
Sep 30, 2021 1.24 Mn
API Access

UroGen Pharma Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=URGN&period=max&api_key=YOUR_API_KEY